These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 22486471

  • 1. West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic.
    Francis RO, Strauss D, Williams JD, Whaley S, Shaz BH.
    Transfusion; 2012 Dec; 52(12):2664-70. PubMed ID: 22486471
    [Abstract] [Full Text] [Related]

  • 2. A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus.
    Biggerstaff BJ, Petersen LR.
    Transfusion; 2009 Jun; 49(6):1151-9. PubMed ID: 19309472
    [Abstract] [Full Text] [Related]

  • 3. West Nile virus testing experience in 2007: evaluation of different criteria for triggering individual-donation nucleic acid testing.
    Kleinman SH, Williams JD, Robertson G, Caglioti S, Williams RC, Spizman R, Morgan L, Tomasulo P, Busch MP.
    Transfusion; 2009 Jun; 49(6):1160-70. PubMed ID: 19320866
    [Abstract] [Full Text] [Related]

  • 4. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing.
    Busch MP, Caglioti S, Robertson EF, McAuley JD, Tobler LH, Kamel H, Linnen JM, Shyamala V, Tomasulo P, Kleinman SH.
    N Engl J Med; 2005 Aug 04; 353(5):460-7. PubMed ID: 16079369
    [Abstract] [Full Text] [Related]

  • 5. West Nile virus in 2006 and 2007: the Canadian Blood Services' experience.
    O'Brien SF, Scalia V, Zuber E, Hawes G, Alport EC, Goldman M, Fearon MA.
    Transfusion; 2010 May 04; 50(5):1118-25. PubMed ID: 20051051
    [Abstract] [Full Text] [Related]

  • 6. West Nile virus in Canadian blood donors.
    Cameron C, Reeves J, Antonishyn N, Tilley P, Alport T, Eurich B, Towns D, Lane D, Saldanha J.
    Transfusion; 2005 Apr 04; 45(4):487-91. PubMed ID: 15819667
    [Abstract] [Full Text] [Related]

  • 7. Triggers for switching from minipool testing by nucleic acid technology to individual-donation nucleic acid testing for West Nile virus: analysis of 2003 data to inform 2004 decision making.
    Custer B, Tomasulo PA, Murphy EL, Caglioti S, Harpool D, McEvoy P, Busch MP.
    Transfusion; 2004 Nov 04; 44(11):1547-54. PubMed ID: 15504158
    [Abstract] [Full Text] [Related]

  • 8. Reacting to an emerging safety threat: West Nile virus in North America.
    Stramer SL.
    Dev Biol (Basel); 2007 Nov 04; 127():43-58. PubMed ID: 17486880
    [Abstract] [Full Text] [Related]

  • 9. The 2003 West Nile virus United States epidemic: the America's Blood Centers experience.
    Kleinman S, Glynn SA, Busch M, Todd D, Powell L, Pietrelli L, Nemo G, Schreiber G, Bianco C, Katz L, NHLBI Retrovirus Epidemiology Study (REDS).
    Transfusion; 2005 Apr 04; 45(4):469-79. PubMed ID: 15819665
    [Abstract] [Full Text] [Related]

  • 10. West Nile virus among blood donors in the United States, 2003 and 2004.
    Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP, Dodd RY.
    N Engl J Med; 2005 Aug 04; 353(5):451-9. PubMed ID: 16079368
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of West Nile virus RNA and antibody in frozen plasma components from a voluntary market withdrawal during the 2002 peak epidemic.
    Tobler LH, Bianco C, Glynn SA, Schreiber GB, Dille BJ, Prince HE, Lanciotti RS, Linnen JM, Gallarda J, Shyamala V, Smith D, Kleinman SH, Busch MP, NHLBI Retrovirus Epidemiology Study (REDS).
    Transfusion; 2005 Apr 04; 45(4):480-6. PubMed ID: 15819666
    [Abstract] [Full Text] [Related]

  • 14. A probable case of West Nile virus transfusion transmission.
    Groves JA, Shafi H, Nomura JH, Herron RM, Baez D, Dodd RY, Stramer SL.
    Transfusion; 2017 Mar 04; 57(3pt2):850-856. PubMed ID: 28164314
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. West Nile virus infections projected from blood donor screening data, United States, 2003.
    Busch MP, Wright DJ, Custer B, Tobler LH, Stramer SL, Kleinman SH, Prince HE, Bianco C, Foster G, Petersen LR, Nemo G, Glynn SA.
    Emerg Infect Dis; 2006 Mar 04; 12(3):395-402. PubMed ID: 16704775
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Feasibility of routine individual donation testing for West Nile virus RNA during epidemic season using the investigational Roche cobas TaqScreen West Nile virus test and cobas s 201 system prototype.
    Galel SA, Webster J, Roa L.
    Transfusion; 2008 Jul 04; 48(7):1486-94. PubMed ID: 18466179
    [Abstract] [Full Text] [Related]

  • 19. Probable transfusion transmission of West Nile virus from an apheresis platelet that screened non-reactive by individual donor-nucleic acid testing.
    Hayes C, Stephens L, Fridey JL, Snyder RE, Groves JA, Stramer SL, Klapper E.
    Transfusion; 2020 Feb 04; 60(2):424-429. PubMed ID: 31633814
    [Abstract] [Full Text] [Related]

  • 20. Analytical and clinical sensitivity of West Nile virus RNA screening and supplemental assays available in 2003.
    Busch MP, Tobler LH, Saldanha J, Caglioti S, Shyamala V, Linnen JM, Gallarda J, Phelps B, Smith RI, Drebot M, Kleinman SH.
    Transfusion; 2005 Apr 04; 45(4):492-9. PubMed ID: 15819668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.